The placebo effect in clinical trials for alcohol dependence: an exploratory analysis of 51 naltrexone and acamprosate studies
about
Advances in Medications and Tailoring Treatment for Alcohol Use DisorderRecommendations for the Design and Analysis of Treatment Trials for Alcohol Use DisordersNetwork analysis of the genomic basis of the placebo effect.Alcohol use disorder: pathophysiology, effects, and pharmacologic options for treatmentThe impact of focusing a program to prevent heavier drinking on a pre-existing phenotype, the low level of response to alcohol.Placebo eff ects in psychiatry: mediators and moderators.Age and sex as moderators of the placebo response – an evaluation of systematic reviews and meta-analyses across medicineDiscovery, Development, and Adoption of Medications to Treat Alcohol Use Disorder: Goals for the Phases of Medications DevelopmentAcceptability and feasibility of a randomized clinical trial of oral naltrexone vs. placebo for women living with HIV infection: Study design challenges and pilot study results.Role of placebo effects in pain and neuropsychiatric disorders.Review article: pharmacotherapy for alcohol dependence - the why, the what and the wherefore.The placebo effect and its clinical associations in gambling disorderPrazosin for Veterans with Posttraumatic Stress Disorder and Comorbid Alcohol Dependence: A Clinical Trial.Precision Medicine in Alcohol Dependence: A Controlled Trial Testing Pharmacotherapy Response Among Reward and Relief Drinking Phenotypes.Mecamylamine treatment for alcohol dependence: a randomized controlled trial.A Double-Blind Randomized Placebo-Controlled Trial of Oral Naltrexone for Heavy-Drinking Smokers Seeking Smoking Cessation Treatment.Both active and sham low-frequency rTMS single sessions over the right DLPFC decrease cue-induced cravings among pathological gamblers seeking treatment: A randomized, double-blind, sham-controlled crossover trial.
P2860
Q26799814-5F6A8532-9EDB-406F-A8E0-0AB8741F34A2Q27013929-7EFE53B9-A740-42B8-B573-B353A59641EEQ33752381-2610DD52-0007-4494-ABE3-EA9472C33FB7Q34411076-AF46F177-A8BD-4800-94BF-CF6C0AC0403AQ35091387-F62E5EFF-EAF5-48FB-B947-822AE1856359Q35207492-8AA7F935-A548-4F49-8A9B-66B71A8AA4C0Q35513153-AAB5EAD8-AB23-4873-8C6E-93F6BDB7FA70Q37059221-E1DC3016-96DE-4E05-8F93-0F2F957CF3F7Q38667801-90229DFF-B2A9-4C58-B875-3F7048AC54E3Q38673105-0366F4A2-14EE-4FB8-B631-FF89933F2DE2Q39144955-2380492E-C5CD-41B4-A2C7-F26CCE874DEEQ41211388-F8CD4A3D-F8E0-4341-86BD-43D7A385883CQ45327806-A8CAEF7A-237D-4F8A-B9CA-CAAC5DE72A74Q47572906-1A5A3F30-E3E9-4768-9B9D-E5A5137E28A8Q47667884-B4A88C77-F40F-4ACC-B9BA-35C6263BAA7CQ47915520-B265DC97-1C5C-4AAA-B4A4-2AFBDDDECD72Q49797831-0C4037FD-2665-4E54-A051-F849D3E0405C
P2860
The placebo effect in clinical trials for alcohol dependence: an exploratory analysis of 51 naltrexone and acamprosate studies
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The placebo effect in clinical ...... rexone and acamprosate studies
@en
The placebo effect in clinical ...... exone and acamprosate studies.
@nl
type
label
The placebo effect in clinical ...... rexone and acamprosate studies
@en
The placebo effect in clinical ...... exone and acamprosate studies.
@nl
prefLabel
The placebo effect in clinical ...... rexone and acamprosate studies
@en
The placebo effect in clinical ...... exone and acamprosate studies.
@nl
P2093
P2860
P356
P1476
The placebo effect in clinical ...... rexone and acamprosate studies
@en
P2093
Chiung M Chen
Daniel Falk
Hsiao-ye Yi
I-Jen P Castle
Joanne Fertig
Megan Ryan
Raye Z Litten
P2860
P304
P356
10.1111/ACER.12197
P577
2013-07-24T00:00:00Z